TrademarkDir
CCURE API
LIVE

Serial Number

79311676

Owner

LABORATORIOS ESPINOS Y BOFILL, S.A.

Attorney

Roberto Ledesma

Filing Date

Mar 8, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CCURE API Trademark

Serial Number: 79311676 • Registration: 6720837

CCURE API is a trademark filed by LABORATORIOS ESPINOS Y BOFILL, S.A. on March 8, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

LABORATORIOS ESPINOS Y BOFILL, S.A.

Ctra. de L'Hospitalet, 30

Entity Type: 85

Selectchemie AG (4 trademarks)

Etzelstrasse 42

Entity Type: 99

Trademark Details

Filing Date

March 8, 2021

Registration Date

May 24, 2022

Published for Opposition

February 22, 2022

Goods & Services

Pharmaceutical and veterinary products, namely, pharmaceutical preparations for treating digestive disorders and parasitic infections; hygienic and sanitary products for medical use, namely antibiotic ointments and wound dressings

Active chemical ingredients for use in the manufacture of pharmaceutical substances for the treatment of diseases or infections pertaining to the following therapeutic areas: Alimentary tract and metabolism , Autoimmune, Bone/ Osteosporosis, Cardiovascular, Central Nervous System, Diabetes, Diagnostic agents, Genito urinary, Inmunology, Endocrine, Gastroenterology, Haematology, Infectious, Inflammation, Internal disease, Mental Health or Psychiatry, Musculo-skeletal system, Neurology, Oncology, Orthopaedics , Pulmonology, Respiratory, Rheumatology, Sensory Organs

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 17, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Sep 9, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 9, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 24, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 24, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
May 24, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 22, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 22, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Feb 20, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 2, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 2, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 2, 2022 NONP
ASSIGNED TO LIE
Jan 19, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 19, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 19, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 19, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 19, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 19, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 3, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 3, 2022 TROA
REFUSAL PROCESSED BY IB
Dec 6, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 16, 2021 RFCS
REFUSAL PROCESSED BY MPU
Nov 16, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 12, 2021 RFCR
NON-FINAL ACTION WRITTEN
Nov 11, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 9, 2021 DOCK
ASSIGNED TO EXAMINER
Sep 29, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 1, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 27, 2021 REPR

Related Trademarks

More from this Owner

SELECTCHEMIE

SELECTCHEMIE

SELECTCHEMIE

SELECTCHEMIE

SELECTCHEMIE

SELECTCHEMIE

SELECT PHARMA logo

SELECT PHARMA

S logo

S

SELECT PHARMA logo

SELECT PHARMA